Journal of Pathology and Disease Biology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 1518081136

Book Review - Journal of Pathology and Disease Biology (2023) Volume 7, Issue 4

Precision Medicine in Pathology

Hong Shu *

Department of Genetics, Stanford University, California, US

*Corresponding Author:
Hong Shu
Department of Genetics, Stanford University, California, US
E-mail: shuhong@standard.edu

Received: 05- Aug -2023, Manuscript No. AAPDB-23-112342; Editor assigned: 06- Aug -2023, PreQC No. AAPDB-23-112342; Reviewed:19- Aug -2023, QC No. AAPDB-23-112342; Revised:21- Aug -2023, Manuscript No. AAPDB-23-112342 (R); Published:28- Aug -2023, DOI:10.35841/ aatcc -7.4.165

Citation: Shu H. Precision Medicine in Pathology. J Pathol Dis Biol. 2023;7(4):165

Visit for more related articles at Journal of Pathology and Disease Biology

Introduction

The field of medicine has undergone a remarkable transformation in recent years, moving from a one-size-fits-all approach to a more personalized and precise model of care. This shift is particularly evident in pathology, where the application of precision medicine has the potential to revolutionize disease diagnosis, treatment, and prognosis. Precision medicine in pathology involves tailoring medical decisions and treatments to individual patient characteristics, including genetic makeup, molecular profiles, and environmental factors. In this article, we will explore the concept of precision medicine in pathology and its far-reaching implications for healthcare [1].

Traditionally, pathology involved the examination of tissues, cells, and bodily fluids to diagnose diseases and guide treatment decisions. Pathologists primarily relied on macroscopic and microscopic observations to make diagnoses, often categorizing diseases based on histological patterns. While this approach has been invaluable in many cases, it has limitations, particularly when it comes to understanding the underlying molecular and genetic drivers of diseases [2].

Precision medicine in pathology represents a paradigm shift, where diagnoses and treatment plans are guided by an in-depth understanding of a patient's unique biological characteristics. Key elements of precision medicine in pathology include: Genomic Profiling: Genomic analysis involves sequencing a patient's DNA to identify genetic mutations or alterations associated with diseases. This information can help predict disease risk, guide treatment choices, and even identify potential therapeutic targets. Molecular Pathology: Molecular pathology focuses on the study of molecular and cellular changes in tissues and cells. It includes techniques like immunohistochemistry and in situ hybridization to detect specific proteins or genetic material within tissues, aiding in the diagnosis and classification of diseases [3].

Biomarker Identification: Biomarkers are specific molecules, genes, or characteristics that can serve as indicators of disease or treatment response. Identifying and measuring biomarkers can assist in diagnosis, prognosis, and treatment selection. Targeted Therapies: Precision medicine allows for the development of targeted therapies that specifically address the molecular or genetic abnormalities driving a disease. These therapies are often more effective and have fewer side effects compared to traditional treatments [4].

Cancer: Cancer has been at the forefront of precision medicine in pathology. Genomic profiling of tumor tissue can identify specific genetic mutations or alterations that drive cancer growth. Targeted therapies, such as tyrosine kinase inhibitors for EGFR-mutated lung cancer or PARP inhibitors for BRCA-mutated breast cancer, have transformed cancer treatment by precisely targeting the underlying molecular abnormalities. Infectious Diseases: Precision medicine also plays a role in the diagnosis and treatment of infectious diseases. For instance, genomic analysis of pathogens helps identify drug resistance mutations, allowing for the selection of appropriate antimicrobial therapies. Additionally, understanding host genetic factors can influence susceptibility to infections [5].

conclusion

Precision medicine in pathology represents a transformative approach to healthcare, shifting from a one-size-fits-all model to one that is tailored to individual patients. This approach is revolutionizing disease diagnosis, treatment, and prognosis, particularly in areas such as cancer, infectious diseases, neurodegenerative disorders, and rare diseases. As technology continues to advance, the field of precision medicine in pathology will likely expand its reach, leading to more accurate diagnoses, better treatment outcomes, and improved patient care. However, challenges such as data integration, cost, and interpretation must be addressed to ensure that precision medicine remains accessible and effective for all patients

References

  1. Bit-Ivan EN, Bigio EH. Neuropathology of neurodegenerative disorders. Progressive Cognitive Impairment and its Neuropathologic Correlates. 2016:1-6.

    2. Google Scholar

  2. Erkkinen MG, Kim MO, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 2018;10(4):a033118.

    3. Indexed at, Google Scholar, Cross Ref

  3. Raz L, Knoefel J, Bhaskar K. The neuropathology and cerebrovascular mechanisms of dementia. J. Cereb. Blood Flow Metab. 2016;36(1):172-86.

    4. Indexed at, Google Scholar, Cross Ref

  4. Koeppen AH. The neuropathology of the adult cerebellum. Cereb. Blood Flow Metab. 2018;154:129-49.

    5. Indexed at, Google Scholar, Cross Ref

  5. Terreros-Roncal J, Moreno-Jiménez EP, Flor-García M, et al. Impact of neurodegenerative diseases on human adult hippocampal neurogenesis. Science. 2021;374(6571):1106-13.

    6. Indexed at, Google Scholar, Cross Ref

Get the App